Addyi
Developed for hypoactive sexual desire disorder indicated to support sexual well-being.
Strengths: 100mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Serotonin Receptor Modulator
- Pharmacological class
5-HT1A Receptor Agonist
- Precautions and warnings
may cause hypotension; avoid driving or operating machinery; monitor for syncope
- Minor side effects
dizziness; somnolence; nausea; fatigue
- Moderate side effects
insomnia; dry mouth
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Sprout Pharmaceuticals
- Onset Time
4–8 weeks
- Duration
Indefinite
- Storage instructions
Store at controlled room temperature.
- Drug interactions
alcohol; ketoconazole
- Age restrictions
Adults only.
Contraindications
alcohol consumption; hepatic impairment; concurrent use of moderate or strong cyp3a4 inhibitors
Serious side effects
syncope — requires immediate medical attention; severe hypotension — requires immediate medical attention
Patient summary
Developed for hypoactive sexual desire disorder indicated to support sexual well-being.
Mechanism of action
Flibanserin acts as a multifunctional serotonin agonist and antagonist, modulating neurotransmitters in the brain to increase sexual desire.
Pregnancy and breastfeeding
Pregnancy: Use only if potential benefit justifies risk. Breastfeeding: Not recommended.
Addyi
Developed for hypoactive sexual desire disorder indicated to support sexual well-being.
Editorial Notes
- Active ingredient(s): Flibanserin
- Listed indication(s): Hypoactive Sexual Desire Disorder
Available option
- 20 tablets - 100 mg1071-100-mg-13165